Medical News

RSS

Vigorous exercise associated with mental illness vulnerability

Contrary to expectations, engagement in vigorous exercise is positively associated with the incidence and prevalence of psychiatric disorders, particularly bipolar II disorder and alcohol dependence, US researchers report.

24 Aug 2012

Prescription drug monitoring systems alert abuse

Electronic prescription monitoring programs may significantly improve drug-abuse detection and could alert clinicians to “doctor shopping,” say researchers.

24 Aug 2012

Radiating fears over diabetes in childhood cancer survivors

People who undergo pancreatic irradiation during childhood cancer therapy are at an increased risk for developing diabetes later in life, report researchers.

24 Aug 2012

Sleep apnea is not necessarily a male disorder

Women, particularly those with hypertension or obesity, have high rates of sleep apnea, study findings show.

24 Aug 2012

Bleeding risk from aneurysm high in hemorrhagic AVM radiosurgery

In patients undergoing stereotactic radiosurgery for hemorrhagic arteriovenous malformations, endovascular or surgical strategies that reduce bleeding risk should be used if an aneurysm is found, advise US researchers.

24 Aug 2012

Incidence of early-onset schizophrenia ‘increasing’

The incidence of diagnosed early-onset schizophrenia has increased in recent years, study results show.

24 Aug 2012

PathGEN signs Powered by Affymetrix Program agreement

Affymetrix, Inc. and PathGEN Dx Pte. Ltd., a spin-off molecular diagnostics company founded by researchers from the Genome Institute of Singapore, today announced they have signed a Powered by Affymetrix (PbA) Program agreement

24 Aug 2012

Novira secures $23M in Series A financing to support antiviral development for HBV, HIV

Novira Therapeutics Inc. today announced it has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.

24 Aug 2012

Lilly’s solanezumab Phase 3 trials on AD do not meet primary endpoints

Eli Lilly and Company today announced that the primary endpoints, both cognitive and functional, were not met in either of the two Phase 3, double-blind, placebo-controlled solanezumab EXPEDITION trials in patients with mild-to-moderate Alzheimer's disease.

24 Aug 2012

Tornier signs definitive agreement to acquire OrthoHelix

Tornier N.V., a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced that it has signed a definitive agreement to acquire OrthoHelix Surgical Designs, Inc. for $135 million plus additional payments over two years, which will be based on achieving certain revenue growth milestones.

24 Aug 2012

First Edition: August 24, 2012

Now on Kaiser Health News blog, KUHF's Carrie Feibel, working in partnership with KHN and NPR, reports: "When Ashley Beecher had her first daughter, nursing was a struggle, and she sometimes had to supplement her baby's diet with formula. But when she had her second daughter in January, it was a very different story. … Beecher was reluctant to throw away the milk – mothers and doctors call it 'liquid gold' because of its health benefits - so she was excited to find out about the donor milk bank at Texas Children's Hospital in Houston."

24 Aug 2012

Herbal plant extract may help cure breast cancer

Scientists at Aston University and Russells Hall Hospital have discovered that an extract from a common plant in Pakistan may help cure breast cancer.

24 Aug 2012

State Senator honors UCLA lung transplant doctors during special ceremony

Dr. Abbas Ardehali, professor of cardiothoracic surgery and director of the UCLA Heart and Lung Transplant program, and Dr. David Ross, professor of pulmonology and medical director of the UCLA Lung Transplant program, were honored by State Senator Sharon Runner (R-Antelope Valley) during a special ceremony at the State Senate Chamber in Sacramento on Aug. 21.

24 Aug 2012

Quantitative look at the whole experience of patients with pancreatic cancer

Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.

24 Aug 2012

Aetna sponsorship provides support for children's activities at the US Open

For the second year, Aetna is sponsoring children's activities at the US Open and is determined to deliver twice the fun as part of its three-year sponsorship agreement with the United States Tennis Association (USTA).

24 Aug 2012

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Tuberculosis (TB) is second only to HIV/AIDS as the greatest killer worldwide attributable to a single infectious agent, according to the World Health Organization (WHO). With 8.8 million cases in 2010 and 95 percent of TB deaths occurring in low- and middle-income countries, the disease continues to be a major public health problem in the developing world. In a July address to the International Union Against Tuberculosis and Lung Disease, Dartmouth's C. Fordham (Ford) von Reyn shared news of a promising vaccine in the works.

24 Aug 2012

Pre-emptive therapy better than valacyclovir prophylaxis in treating CMV in transplant recipients

Waiting to treat the commonest viral infections in transplant recipients until they reach a certain threshold is better than prophylactically treating all recipients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

24 Aug 2012

Guidelines for parents to beat back-to-school bugs

School bells are beginning to sound again across the country, so it will only be a matter of time until every parent comes face-to-face with a child who wakes up with a cold, fever or upset stomach.

24 Aug 2012

Diabetes journal reports results from novel experimental therapy

Results from a novel experimental therapy for Type 1 diabetes that boosts parts of the healthy immune system are reported today in the scientific journal Diabetes.

24 Aug 2012

Study highlights importance of using appropriately treated water for sinus irrigation

When water containing the Naegleria fowleri ameba, a single-celled organism, enters the nose, the organisms may migrate to the brain, causing primary amebic meningoencephalitis, a very rare-but usually fatal-disease. A new study published in Clinical Infectious Diseases describes the first reported cases in the United States implicating nasal irrigation using disinfected tap water in these infections.

24 Aug 2012